☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
BridgeBio Entered into a Collaboration with Helsinn to Co-Develop and Co-Commercialize GPX4 Program for Multiple Cancer
November 22, 2021
Innovent Presents Results of Sintilimab + Byvasda (biosimilar, bevacizumab) in P-III ORIENT-31 Study for EGFR-Mutated Non squamous...
November 22, 2021
CStone Signs an Exclusive License Agreement with Jiangsu Hengrui to Develop and Commercialize CS1002 in Greater China
November 22, 2021
Gilead Submits BLA to US FDA for Bulevirtide to Treat Chronic Hepatitis Delta Virus Infection
November 22, 2021
Zenas Acquires Exclusive WW Rights of Xencor's obexelimab for the Treatment of Autoimmune Diseases
November 22, 2021
UCB Reports Interim Results of Bimekizumab in P-III BE OPTIMAL Study for the Treatment of Active Psoriatic Arthritis
November 22, 2021
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions